Sign in Check my fit
EN
Home / US Department of Defense / HT942526TBDRPTDRA

DoW Tick-Borne Disease Therapeutic/Diagnostic Research Award

Open now · Grant · HT942526TBDRPTDRA

Next cut-off
22 Oct '26
in 46 days
Per grant
$1.3M
the call's own average
Grants expected
2
projects that will be funded
Funding rate
,
not published, read the conditions

In context of US Department of Defense

This grant$1.3M
The track runs to the largest grant in US Department of Defense ($1000M). The median across the 126 calls we publish is $1.5M, this one is below it.

What this call funds

Summary: The intent of the fiscal year 2026 (FY26) Tick-Borne Disease Research Program (TBDRP) Therapeutic/Diagnostic Research Award (TDRA) is to support product-driven therapeutic and diagnostic development research aimed at reducing the burden of Lyme disease and/or other tick-borne diseases and conditions, and improving patient care and/or quality of life. Treatment-focused applications should be therapeutic evaluation studies designed to advance new ideas aimed at drug or treatment discovery that are still in the early/preclinical stages of development. Diagnosis-focused applications should propose diagnostic approaches that will be readily integrated into clinical settings.

https://cdmrp.health.mil/pubs/press/2026/tbdrppreann

What applying costs you

ItemEstimateNote
Drafting effort3–4 weekssingle submission
Time to first payment6–9 monthscut-off → evaluation → grant agreement

These are Bemzu's estimates from the call's structure (the number of stages and whether a consortium is required) not figures published by the Commission. Only the co-financing share is read from the call itself.

Also open in DOD

Become the beneficiary.

Eight questions, no account, nothing sent anywhere. You will know which of the 1526 open calls you can actually enter before you finish your coffee.

Check my fit